Announcements Trials
Browse Landscape

Phase

Phase 2 1Phase 1 1

Status

Completed 2

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Interventional 2

Sponsor

Cancer Type

Thoracic 2

Conditions

Pancreatic Neoplasms 43Carcinoma, Non-Small-Cell Lung 35Breast Neoplasms 35Triple Negative Breast Neoplasms 16Neoplasms 15Neoplasm Metastasis 14Carcinoma 9Adenocarcinoma 9Lung Neoplasms 7Head and Neck Neoplasms 6Colorectal Neoplasms 6Squamous Cell Carcinoma of Head and Neck 5Parkinson Disease 4, Autosomal Dominant Lewy Body 5Pancreatic Diseases 5Cholangiocarcinoma 5Carcinoma, Squamous Cell 5Neoplasms by Site 4Melanoma 4Digestive System Neoplasms 4Digestive System Diseases 4Sarcoma 3Pancreatic Adenocarcinoma 3Neoplasms by Histologic Type 3Inflammatory Breast Neoplasms 3Endocrine System Diseases 3Endocrine Gland Neoplasms 3Carcinoma, Pancreatic Ductal 3Carcinoma, Ovarian Epithelial 3Uveal Melanoma 2Urinary Bladder Neoplasms 2

Interventions

Carboplatin 42Etoposide 37Cisplatin 23Topotecan 22Nivolumab 17pembrolizumab 12atezolizumab 12Ipilimumab 10Paclitaxel 9durvalumab 8Irinotecan 8Radiosurgery 6Pemetrexed 6rovalpituzumab tesirine 5Magnetic Resonance Spectroscopy 5trioctyl phosphine oxide 4trilaciclib 4etoposide phosphate 4berzosertib 4Sunitinib 4Specimen Handling 4Platinum 4PM 01183 4Dexamethasone 4veliparib 3tremelimumab 3olaparib 3carfilzomib 3cabozantinib 3Temozolomide 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Has results × Small Cell Lung Carcinoma × 130-nm albumin-bound paclitaxel × Clear all
NCT02769832 2025-07-29

Nab-Paclitaxel With Gemcitabine for Relapsed Small Cell Cancer

University of Iowa

Phase 2 Completed
32 enrolled 12 charts
Thoracic

Small Cell Lung Carcinoma

NCT01840579 2021-06-22

MK-3475-011

Merck Sharp & Dohme LLC

Phase 1 Completed
57 enrolled 60 charts
Thoracic

Carcinoma, Non-Small-Cell Lung, Small Cell Lung Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡